| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |